Daejeon, Taejon-jikhalsi, South Korea Related Funds
| Fund Name | Location |
| Alacrity India | India, Maharashtra, Pune |
| Asia Summit Capital | China, Hong Kong, Hong Kong Island |
| DFJ QuickCare Holding | China, Hong Kong, Hong Kong Island |
| Global Insurance Accelerator | Des Moines, Iowa, United States |
| Ixora Ventures | Delhi, India, New Delhi |
| Kxter Fund One | California, San Francisco, United States |
| Mariner Partners | Canada, New Brunswick, Saint John |
| Nanwang Ziben | China, Guangdong, Guangzhou |
| re.Mind Capital | Central Region, Malta, NA - Malta |
| Saibugas Group | - |
| SAIC Motor | China, Shanghai |
| Sanquan Foods | China, Henan, Zhengzhou |
| Schwan's Shared Services,LLC | Marshall, Minnesota, United States |
| Sella Ventures | - |
| Shanghai Jingerwei Data Technology | China, Shanghai |
| Shirong Investment Management | China, Guangdong, Guangzhou |
| The Andan Foundation | Obwalden, Sarnen, Switzerland |
| Valiance Asset Management | Castel, Guernsey, Guernsey |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Medi Plus Solution | $12M | 30 Jul 2021 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Solivis | 01 Dec 2020 | Kyonggi-do, Gyeonggi-do, South Korea |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Medi Plus Solution | $12M | 30 Jul 2021 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Solivis | 01 Dec 2020 | Kyonggi-do, Gyeonggi-do, South Korea |
